HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yung-Luen Yu Selected Research

Immunotherapy

8/2021The Function of the Mutant p53-R175H in Cancer.
3/2013Long-term expression of rAAV2-hIL15 enhances immunoglobulin production and lymphokine-activated killer cell-mediated human glioblastoma cell death.
5/2012Immunotherapy for SV40 T/t antigen-induced breast cancer by recombinant adeno-associated virus serotype 2 carrying interleukin-15 in mice.
2/2010Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression.
5/2009Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yung-Luen Yu Research Topics

Disease

41Neoplasms (Cancer)
09/2023 - 05/2009
13Breast Neoplasms (Breast Cancer)
03/2019 - 12/2006
12Hepatocellular Carcinoma (Hepatoma)
09/2023 - 02/2010
8Triple Negative Breast Neoplasms
01/2021 - 01/2013
7Neoplasm Metastasis (Metastasis)
09/2023 - 04/2013
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 05/2009
4Lung Neoplasms (Lung Cancer)
01/2017 - 05/2009
4Glioblastoma (Glioblastoma Multiforme)
06/2015 - 08/2008
3Brain Neoplasms (Brain Tumor)
06/2015 - 08/2008
3Stroke (Strokes)
10/2013 - 04/2013
2Fibrosis (Cirrhosis)
12/2023 - 06/2014
2Wounds and Injuries (Trauma)
04/2020 - 01/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2020 - 06/2015
2Rheumatoid Arthritis
04/2017 - 09/2014
2Ataxia Telangiectasia (Louis Bar Syndrome)
06/2015 - 07/2014
2Prostatic Neoplasms (Prostate Cancer)
06/2015 - 07/2014
2Pneumonia (Pneumonitis)
04/2014 - 09/2013
2Chronic Hepatitis B
01/2014 - 01/2012
1Chronic Renal Insufficiency
12/2023
1Ureteral Obstruction
12/2023
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2023
1Autoimmune Diseases (Autoimmune Disease)
11/2023
1Nasopharyngeal Carcinoma
04/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1Chondrosarcoma
01/2018
1Cough
01/2018
1Glioma (Gliomas)
01/2018
1Pain (Aches)
01/2018

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
12/2023 - 05/2012
5MicroRNAs (MicroRNA)IBA
09/2023 - 12/2013
5ErbB Receptors (EGF Receptor)IBA
07/2014 - 07/2009
4Messenger RNA (mRNA)IBA
09/2023 - 04/2011
4Estrogen ReceptorsIBA
01/2020 - 03/2011
4human ERBB2 proteinIBA
01/2020 - 04/2013
4Ribonucleases (Ribonuclease)IBA
06/2015 - 03/2011
3Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 11/2013
3Methotrexate (Mexate)FDA LinkGeneric
03/2019 - 09/2014
3Matrix Metalloproteinases (MMPs)IBA
01/2018 - 09/2013
3Histones (Histone)IBA
01/2018 - 07/2014
3Peptides (Polypeptides)IBA
01/2017 - 01/2013
3Interleukin-15 (Interleukin 15)IBA
05/2012 - 05/2009
2mangostinIBA
12/2023 - 01/2020
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2023 - 09/2014
2AntigensIBA
09/2023 - 04/2014
2praeruptorin AIBA
04/2021 - 04/2020
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 01/2016
2Enhancer of Zeste Homolog 2 ProteinIBA
07/2020 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2012
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
04/2017 - 09/2014
2TubulinIBA
01/2016 - 06/2015
2Caspase 9IBA
06/2015 - 09/2014
2DNA-Activated Protein KinaseIBA
06/2015 - 09/2012
2Phosphotransferases (Kinase)IBA
06/2015 - 04/2013
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
04/2014 - 01/2013
2Polysaccharides (Glycans)IBA
01/2014 - 01/2012
2Tyrosine Kinase InhibitorsIBA
11/2013 - 04/2011
2Lapatinib (GW572016)FDA Link
11/2013 - 04/2013
2Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2013 - 12/2006
2Epidermal Growth Factor (EGF)IBA
09/2010 - 07/2009
2butylidenephthalideIBA
02/2010 - 08/2008
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
12/2023
1U 0126 (UO 126)IBA
12/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2023
1Cadherins (E-Cadherin)IBA
12/2023
1CollagenIBA
12/2023
1VimentinIBA
12/2023
1Fibronectins (Fibronectin)IBA
12/2023
1Tripartite Motif ProteinsIBA
11/2023
1hepatitis B virus X proteinIBA
09/2023
1MucinsIBA
01/2022
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2021
1capsanthinIBA
01/2021
1Chemokine ReceptorsIBA
07/2020
1salvianolic acid AIBA
04/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2020
1anomalinIBA
04/2020
1praeruptorin CIBA
04/2020
1LycopeneIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1Hormones (Hormone)IBA
01/2020
1Folic Acid (Vitamin M)FDA LinkGeneric
03/2019
1Succinic Acid (Succinate)IBA
03/2019
1Vitamin EFDA LinkGeneric
03/2019
1Sulfates (Sulfates, Inorganic)IBA
01/2019
1Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2019
1alpha-TocopherolFDA Link
01/2019
1aristolochic acid I (aristolochic acid)IBA
01/2018
1BAY 11-7085IBA
01/2018
1Lysine (L-Lysine)FDA Link
01/2018
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Complementary DNA (cDNA)IBA
01/2018
1Tissue Inhibitor of MetalloproteinasesIBA
01/2018
1Cyclin B1IBA
01/2018

Therapy/Procedure

10Therapeutics
01/2021 - 05/2009
5Immunotherapy
08/2021 - 05/2009
5Drug Therapy (Chemotherapy)
01/2020 - 08/2008
3Radiotherapy
07/2014 - 09/2012